Clinical Trials Browser

Completed × Advanced Solid Tumours × durvalumab × Clear all

NCT02617277 2026-03-04

Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours